| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/21/2006 | WO2006072830A3 Polymorphic and amorphous forms of 2-{3-[(e)-2-(4,6-dimethyl-pyridin-2-yl)-vinyl]-1h-indazol-6-ylamino}-n-(4-hydroxy-but-2-ynyl)benzamide |
| 09/21/2006 | WO2006065590A3 Pyridine and pyrimidine antiviral compositions |
| 09/21/2006 | WO2006061373A3 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 09/21/2006 | WO2006055760A9 Triazole compounds that modulate hsp90 activity |
| 09/21/2006 | WO2006048152A3 Dicarboxamide derivatives and their use as factor xa inhibitors |
| 09/21/2006 | WO2006046734A3 Novel aminopyridine derivatives having selective aurora-a inhibitory effect |
| 09/21/2006 | WO2006002421A3 Modulators of atp-binding cassette transporters |
| 09/21/2006 | US20060211865 Use of pyridine N-oxide analogs at doses which do not induce emesis |
| 09/21/2006 | US20060211735 4-Arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor |
| 09/21/2006 | US20060211734 (Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists |
| 09/21/2006 | US20060211728 Thalidomide analogs |
| 09/21/2006 | US20060211722 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/21/2006 | US20060211719 Heteroaryl aminoguanidine and alkoxyguanidines and their use as protease inhibitors |
| 09/21/2006 | US20060211717 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/21/2006 | US20060211707 Piperazine-alkyl-ureido derivatives |
| 09/21/2006 | US20060211706 e.g. 3-Bromo-8,11-dichloro-6,11-dihydro[5,6]cyclohepta[1,2-b]pyridine deivative; anticarcinogenic agents |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211692 reacting cis-hydroxy-D-proline with 4-chlorophenyl iso-cyanate forming intermediate 1(4-chlorophenylcarbamoyl)-4-hydroxypyrrolidine-2-carboxylic acid, reacting intermediate with aminophenylmorpholinone; 1-[(4-chlorophenyl)]-2-{[4-(3-oxomorpholin-4-yl)phenyl]}-(2R)-pyrrolidine-1,2-dicarboxamide |
| 09/21/2006 | US20060211689 Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 09/21/2006 | US20060211682 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/21/2006 | US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 09/21/2006 | US20060211679 Substituted lactams as inhibitors of Abeta protein production |
| 09/21/2006 | US20060211674 Combination comprising a vasculostatic compound and an alkylating agent for the treatment of a tumor |
| 09/21/2006 | US20060211577 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | US20060211028 Dimeric and trimeric nucleic acid dyes, and associated systems and methods |
| 09/21/2006 | DE102005012874A1 Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Amide substituted 8-N-benzimidazoles, process for their preparation and their use as medicaments |
| 09/21/2006 | CA2759162A1 Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors |
| 09/21/2006 | CA2602173A1 Dpp-iv inhibitors |
| 09/21/2006 | CA2601674A1 Process for the preparation of opioid modulators |
| 09/21/2006 | CA2601628A1 Certain substituted amides, method of making, and method of use thereof |
| 09/21/2006 | CA2601527A1 Potassium channel modulating agents and their medical use |
| 09/21/2006 | CA2601481A1 Process for the preparation of opioid modulators |
| 09/21/2006 | CA2601455A1 Dimeric and trimeric nucleic acid dyes, and associated systems and methods |
| 09/21/2006 | CA2601257A1 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 09/21/2006 | CA2600868A1 Quinazolinone t-type calcium channel antagonists |
| 09/21/2006 | CA2600528A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | CA2600508A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |
| 09/21/2006 | CA2600507A1 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication |
| 09/21/2006 | CA2600038A1 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 09/21/2006 | CA2599925A1 Cgrp receptor antagonists |
| 09/21/2006 | CA2599637A1 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof |
| 09/21/2006 | CA2599538A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | CA2599476A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1702919A1 Novel 2-heteroaryl-substituted benzimidazole derivative |
| 09/20/2006 | EP1702917A1 Amide derivative and medicine |
| 09/20/2006 | EP1702916A1 DPP-IV inhibitors |
| 09/20/2006 | EP1702617A1 Cannabimimetic indole derivatives |
| 09/20/2006 | EP1701959A1 Triazole derivatives as vasopressin antagonists |
| 09/20/2006 | EP1701951A2 Modulators of peripheral 5-ht receptors |
| 09/20/2006 | EP1701944A2 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases |
| 09/20/2006 | EP1701940A1 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 09/20/2006 | EP1509491B1 Intermediate products, methods for their preparation and use thereof |
| 09/20/2006 | EP1392363B1 Use of mGLuR5 antagonists in the manufacture of a medicament in the treatment of Fragile X syndrome, Autism and Mental Retardation |
| 09/20/2006 | EP1366027B1 Combi-molecules having signal transduction inhibitory properties and dna damaging properties |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1343780B1 Piperazine derivatives for treatment of bacterial infections |
| 09/20/2006 | EP1263734B1 3-thiomethylpyrazoles as pesticides |
| 09/20/2006 | EP1246801B1 Methods for the syntheses of alfentanil, sufentanil and remifentanil |
| 09/20/2006 | EP1244627B1 Picolinic acid derivatives and their use as fungicides |
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/20/2006 | EP0799037B1 Compositions for treating allergic rhinitis and other disorders comprising descarboethoxyloratadine |
| 09/20/2006 | CN1835945A Chinazoline derivatives as aurora kinase inhibitors |
| 09/20/2006 | CN1835944A Quinolyl amide derivatives as CCR-5 antagonists |
| 09/20/2006 | CN1835943A 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/20/2006 | CN1835942A Mucin synthesis inhibitors |
| 09/20/2006 | CN1835929A 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 09/20/2006 | CN1835924A Fused compounds that inhibit vanilloid receptor subtype 1(vr1) receptor |
| 09/20/2006 | CN1835751A Therapeutic agents useful for treating pain |
| 09/20/2006 | CN1834094A Terdentate ligand contg. heteroaryl pyrazole, its Eu complex and electroluminescent element |
| 09/20/2006 | CN1276254C Testing method for filtering experimental compound and reagent box |
| 09/20/2006 | CN1276035C Water-color ink |
| 09/20/2006 | CN1275967C Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 09/20/2006 | CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/19/2006 | US7109351 Fused pyrrolecarboxamides; GABA brain receptor ligands |
| 09/19/2006 | US7109338 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 09/19/2006 | US7109337 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/19/2006 | US7109336 Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same |
| 09/19/2006 | US7109335 5-[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-1,3-dihydro-indol-2-one; inhibitors of the FAK protein tyrosine kinases, antiproliferative, antitumor |
| 09/19/2006 | US7109239 for oral administration using sustained release dosage forms; baclofen and baclofen analogs |
| 09/19/2006 | US7109228 Pyrazole derivatives |
| 09/19/2006 | US7109220 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma |
| 09/19/2006 | US7109219 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 09/19/2006 | US7109216 For therapy of psychiatric and neurological disorders |
| 09/19/2006 | US7109215 Compounds possessing neuronal activity |
| 09/19/2006 | US7109211 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 09/19/2006 | US7109207 Used to treat metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 09/19/2006 | US7109201 5-HT1D receptor antagonist activity; antidepressants |
| 09/19/2006 | US7109200 Carbamate derivatives, process for producing the same and use thereof |
| 09/19/2006 | US7109197 Plant safening agents; nematocides; fungicides; bactericides; viricides |
| 09/19/2006 | US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer |
| 09/19/2006 | US7109186 4-hydroxy-5-oxo-1-(2-[4-methylpiperazin-1-yl]ethyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid (3,4-dichlorobenzyl)-methyl-amide for human immunodeficiency virus (HIV) treatment |
| 09/19/2006 | US7109150 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture |
| 09/19/2006 | CA2240845C New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/19/2006 | CA2149459C Acylated aminoalkanimidazoles and -triazoles |
| 09/14/2006 | WO2006096652A2 Process for preparing macrocyclic compounds |
| 09/14/2006 | WO2006096358A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists |
| 09/14/2006 | WO2006095922A1 Tetrahydroisoquinoline compound and medicinal use thereof |
| 09/14/2006 | WO2006095713A1 Inhibitor of plasminogen activator inhibitor-1 |